CMG Pharmaceutical Co., Ltd. (KOSDAQ:058820)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,773.00
+29.00 (1.66%)
Apr 10, 2026, 3:30 PM KST
Market Cap257.84B +0.9%
Revenue (ttm)105.23B +6.2%
Net Income-10.08B
EPS-70.00
Shares Out147.84M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume554,198
Average Volume949,817
Open1,750.00
Previous Close1,744.00
Day's Range1,750.00 - 1,788.00
52-Week Range1,670.00 - 3,345.00
Beta0.64
RSI47.84
Earnings DateApr 3, 2026

About CMG Pharmaceutical

CMG Pharmaceutical Co., Ltd., a pharmaceutical company, develops and sells oral thin film (OTF) pharmaceuticals in South Korea. It offers Tadalafil OTF products for erectile dysfunction; Entecavir OTF products to treat hepatitis type B; Aripiprazole OTF products for schizophrenia; and Montelukast OTF products to treat asthma and allergic rhinitis. CMG Pharmaceutical Co. Ltd. has a strategic collaboration agreement with Handok Inc. for cancer treatment. The company was formerly known as Skynewpharm Co Ltd and changed its name to CMG Pharmaceutic... [Read more]

Sector Healthcare
Founded 2001
Employees 223
Stock Exchange KOSDAQ
Ticker Symbol 058820
Full Company Profile

Financial Performance

Financial Statements